1.Hickman T-T, Shuman ME, Johnson TA, et al. Association between shunt-responsive idiopathic normal pressure hydrocephalus and alcohol. J Neurosurg 2017;127:240-8.
2.Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure - a treatable syndrome. N Engl J Med 1965;273:117-26.
3.Hakim S. Algunas observaciones sobre la presión del LCR. Sindrome hidrocefalico en el adulto con “presion normal” del L.C.R. (Ph.D. Thesis. Bogotá, Colombia: Universidad Javeriana, 1964.)
4.Saper CB. Is there even such a thing as “idiopathic normal pressure hydrocephalus”? Ann Neurol 2017;82:514-5.
5.Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD. Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology 1992;42:54-9.
6.McGirr A, Mohammed S, Kurlan R, Cusimano MD. Clinical equipoise in idiopathic normal pressure hydrocephalus: a survey of physicians on the need for randomized controlled trials assessing the efficacy of cerebrospinal fluid diversion. J Neurol Sci 2013;333:13-8.
7.Israelsson H, Larsson J, Eklund A, Malm J. Risk factors, comorbidities, quality of life, and complications after surgery in idiopathic normal pressure hydrocephalus: review of the INPH-CRasH study. Neurosurg Focus 2020;49(4):E8.
8.Yamada S, Ishikawa M, Yamaguchi M, Yamamoto K. Longitudinal morphological changes during recovery from brain deformation due to idiopathic normal pressure hydrocephalus after ventriculoperitoneal shunt surgery. Sci Rep 2019;9:17318.
9.Bonney PA, Briggs RG, Wu K, et al. Pathophysiological mechanisms underlying idiopathic normal pressure hydrocephalus: a review of recent insights. Front Aging Neurosci 2022;14:866313.
10.Griffa A, Bommarito G, Assal F, Herrmann FR, Van De Ville D, Allali G. Dynamic functional networks in idiopathic normal pressure hydrocephalus: alterations and reversibility by CSF tap test. Hum Brain Mapp 2021;42:1485-502.
11.Morimoto Y, Yoshida S, Kinoshita A, et al. Nonsense mutation in CFAP43 causes normal-pressure hydrocephalus with ciliary abnormalities. Neurology 2019;92(20):e2364-e2374.
12.Yang HW, Lee S, Yang D, et al. Deletions in CWH43 cause idiopathic normal pressure hydrocephalus. EMBO Mol Med 2021;13(3):e13249.
13.Räsänen J, Heikkinen S, Mäklin K, et al. Risk variants associated with normal pressure hydrocephalus: genome-wide association study in the FinnGen cohort. Neurology 2024;103(5):e209694.
14.Nakajima M, Yamada S, Miyajima M, et al. Guidelines for management of idiopathic normal pressure hydrocephalus (third edition): endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo) 2021;61:6397.
15.Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:S4-16; discussion ii.
16.Martín-Láez R, Caballero-Arzapalo H, López-Menéndez LA, Arango-Lasprilla JC, Vázquez-Barquero A. Epidemiology of idiopathic normal pressure hydrocephalus: a systematic review of the literature. World Neurosurg 2015;84:2002-9.
17.Constantinescu C, Wikkelsø C, Westman E, et al. Prevalence of possible idiopathic normal pressure hydrocephalus in Sweden: a population-based MRI study in 791 70-year-old participants. Neurology 2024;102(2):e208037.
18.Iseki C, Takahashi Y, Adachi M, et al. Prevalence and development of idiopathic normal pressure hydrocephalus: a 16-year longitudinal study in Japan. Acta Neurol Scand 2022;146:680-9.
19.Sundström N, Malm J, Laurell K, et al. Incidence and outcome of surgery for adult hydrocephalus patients in Sweden. Br J Neurosurg 2017;31:21-7.
20.Alvi MA, Brown D, Yolcu Y, et al. Prevalence and trends in management of idiopathic normal pressure hydrocephalus in the United States: insights from the national inpatient sample. World Neurosurg 2021;145:e38-e52.
21.Razay G, Wimmer M, Robertson I. Incidence, diagnostic criteria and outcome following ventriculoperitoneal shunting of idiopathic normal pressure hydrocephalus in a memory clinic population: a prospective observational cross-sectional and cohort study. BMJ Open 2019;9(12):e028103.
22.Marmarou A, Young HF, Aygok GA. Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities. Neurosurg Focus 2007;22(4):E1.
23.Thavarajasingam SG, El-Khatib M, Vemulapalli K, et al. Radiological predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir (Wien) 2023;165:369-419.
24.Williams MA, Nagel SJ, Golomb J, et al. Safety and effectiveness of the assessment and treatment of idiopathic normal pressure hydrocephalus in the Adult Hydrocephalus Clinical Research Network. J Neurosurg 2022;137:1289-301.
25.LeHanka A, Piatt J. Readmission and reoperation for hydrocephalus: a population-based analysis across the spectrum of age. J Neurosurg 2020;134:1210-7.
26.Craven CL, Toma AK, Mostafa T, Patel N, Watkins LD. The predictive value of DESH for shunt responsiveness in idiopathic normal pressure hydrocephalus. J Clin Neurosci 2016;34:294-8.
27.Kockum K, Virhammar J, Riklund K, Söderström L, Larsson E-M, Laurell K. Diagnostic accuracy of the iNPH Radscale in idiopathic normal pressure hydrocephalus. PLoS One 2020;15(4):e0232275.
28.Tisell M, Tullberg M, Hellström P, Edsbagge M, Högfeldt M, Wikkelsö C. Shunt surgery in patients with hydrocephalus and white matter changes. J Neurosurg 2011;114:1432-8.
29.Snöbohm C, Malmberg F, Freyhult E, Kultima K, Fällmar D, Virhammar J. White matter changes should not exclude patients with idiopathic normal pressure hydrocephalus from shunt surgery. Fluids Barriers CNS 2022;19:35.
30.Malm J, Graff-Radford NR, Ishikawa M, et al. Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care: a report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 2013;10:22.
31.Macki M, Mahajan A, Shatz R, et al. Prevalence of alternative diagnoses and implications for management in idiopathic normal pressure hydrocephalus patients. Neurosurgery 2020;87:999-1007.
32.Yang F, Hickman T-T, Tinl M, et al. Quantitative evaluation of changes in gait after extended cerebrospinal fluid drainage for normal pressure hydrocephalus. J Clin Neurosci 2016;28:31-7.
33.Bluett B, Ash E, Farheen A, et al. Clinical features of idiopathic normal pressure hydrocephalus: critical review of objective findings. Mov Disord Clin Pract 2022;10:9-16.
34.Micchia K, Formica C, De Salvo S, et al. Normal pressure hydrocephalus: neurophysiological and neuropsychological aspects: a narrative review. Medicine (Baltimore) 2022;101(9):e28922.
35.Naylor RM, Lenartowicz KA, GraffRadford J, et al. High prevalence of cervical myelopathy in patients with idiopathic normal pressure hydrocephalus. Clin Neurol Neurosurg 2020;197:106099.
36.Campos-Juanatey F, Gutiérrez-Baños JL, Portillo-Martín JA, Zubillaga-Guerrero S. Assessment of the urodynamic diagnosis in patients with urinary incontinence associated with normal pressure hydrocephalus. Neurourol Urodyn 2015;34:465-8.
37.Kehler U, Petersen S. Prevalence of fecal incontinence in normal pressure hydrocephalus: a prospective evaluation of 100 patients. World Neurosurg 2023;178:e1-e5.
38.Kimihira L, Iseki C, Takahashi Y, et al. A multi-center, prospective study on the progression rate of asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on magnetic resonance imaging to idiopathic normal pressure hydrocephalus. J Neurol Sci 2020;419:117166.
39.Wikkelsø C, Hellström P, Klinge PM, Tans JT, European iNPH Multicentre Study Group. The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2013;84:562-8.
40.Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:Suppl 3:S17-S28.
41.Sundström N, Andersson K, Marmarou A, Malm J, Eklund A. Comparison between 3 infusion methods to measure cerebrospinal fluid outflow conductance. J Neurosurg 2010;113:1294-303.
42.Eide PK, Sorteberg W. Diagnostic intracranial pressure monitoring and surgical management in idiopathic normal pressure hydrocephalus: a 6-year review of 214 patients. Neurosurgery 2010;66:80-91.
43.Kahlon B, Sundbärg G, Rehncrona S. Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002;73:721-6.
44.Nunn AC, Jones HE, Morosanu CO, et al. Extended lumbar drainage in idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis of diagnostic test accuracy. Br J Neurosurg 2021;35:285-91.
45.Takeuchi T, Yajima K. Long-term 4 years follow-up study of 482 patients who underwent shunting for idiopathic normal pressure hydrocephalus - course of symptoms and shunt efficacy rates compared by age group. Neurol Med Chir (Tokyo) 2019;59:281-6.
46.Vanninen A, Lukkarinen H, Kokkola T, et al. Cerebrospinal fluid diagnostics of Alzheimer’s disease in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 2023;94:727-36.
47.Pearce RKB, Gontsarova A, Richardson D, et al. Shunting for idiopathic normal pressure hydrocephalus. Cochrane Database Syst Rev 2024;8:CD014923.
48.Luciano MG, Williams MA, Hamilton MG, et al. A randomized trial of shunting for idiopathic normal-pressure hydrocephalus. N Engl J Med 2025;393:2198-209.
49.Xie D, Chen H, Guo X, Liu Y. Comparative study of lumboperitoneal shunt and ventriculoperitoneal shunt in the treatment of idiopathic normal pressure hydrocephalus. Am J Transl Res 2021;13:11917-24.
50.Tudor KI, Tudor M, McCleery J, Car J. Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH). Cochrane Database Syst Rev 2015:CD010033.
51.Andrén K, Tullberg M. Adult hydrocephalus: natural history, clinical outcomes, quality of life, and health economics. Neurosurg Clin N Am 2025;36:171-81.
52.Andrén K, Wikkelsø C, Tisell M, Hellström P. Natural course of idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2014;85:806-10.
53.Andrén K, Wikkelsø C, Hellström P, Tullberg M, Jaraj D. Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus. Eur J Neurol 2021;28:1153-9.
54.Rinaldo L, Bhargav AG, Nesvick CL, Lanzino G, Elder BD. Effect of fixed-setting versus programmable valve on incidence of shunt revision after ventricular shunting for idiopathic normal pressure hydrocephalus. J Neurosurg 2019;133:564-72.
55.Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 2017;140:2691-705.
56.Eide PK. Cellular changes at the glianeuro-vascular interface in definite idiopathic normal pressure hydrocephalus. Front Cell Neurosci 2022;16:981399.
57.Lolansen SD, Rostgaard N, Andreassen SN, et al. Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus. Fluids Barriers CNS 2021;18:54.
58.Lylyk P, Lylyk I, Bleise C, et al. First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt. J Neurointerv Surg 2022;14:495-9.
59.Hochstetler AE, Smith HM, Preston DC, et al. TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus. JCI Insight 2020;5(18):e137646.
